A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination with Immune Therapies in Subjects with Advanced or Metastatic Malignancies

Type of Cancer
Unknown

Sponsor
Incyte

Protocol Number
INCAGN 1949-201

To Learn More Call
(201)-510-0950